Physician profile
Albert Seow
NPI 1326042763
$589.55
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $164 · 2021: $65.19 · 2022: $21.81 · 2023: $14.82 · 2024: $29.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $68.17 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.76 | 2020 | |
| Amgen INC. | $58.80 | 2019-2020 | |
| Ge Healthcare | $57.68 | 2019-2022 | |
| Incyte Corporation | $36.26 | 2019-2020 | |
| Celgene Corporation | $32.47 | 2019 | |
| Eisai INC. | $32.42 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $32.24 | 2019 | |
| Boston Scientific Corporation | $29.13 | 2024 | Embold Fibered |
| Bayer Healthcare Pharmaceuticals INC. | $27.92 | 2019 | |
| Foundation Medicine, INC. | $23.37 | 2020-2021 | |
| Janssen Biotech, INC. | $21.32 | 2019 | |
| Astellas Pharma US INC | $18.35 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.14 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $15.86 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $14.98 | 2019 | |
| Mirati Therapeutics, INC. | $14.82 | 2023 | Krazati |
| Rigel Pharmaceuticals, INC. | $14.56 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Seow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.